首页> 外文OA文献 >Brand vs generic adverse event reporting patterns: An authorized generic-controlled evaluation of cardiovascular medications

【2h】

Brand vs generic adverse event reporting patterns: An authorized generic-controlled evaluation of cardiovascular medications

机译：品牌VS通用不良事件报告模式：授权通用控制的心血管药物评估

代理获取

本网站仅为用户提供外文OA文献查询和代理获取服务，本网站没有原文。下单后我们将采用程序或人工为您竭诚获取高质量的原文，但由于OA文献来源多样且变更频繁，仍可能出现获取不到、文献不完整或与标题不符等情况，如果获取不到我们将提供退款服务。请知悉。

页面导航

著录项
引文网络
相似文献
相关主题

著录项

作者
Y. Alatawi; Md. M. Rahman; N. Cheng; J. Qian; P. L. Peissig; R. L. Berg; C. D. Page; R. A. Hansen;
展开▼
作者单位

展开▼
年度 2017
总页数
原文格式 PDF
正文语种
中图分类

相似文献

外文文献
中文文献
专利

1. Brand vs generic adverse event reporting patterns: An authorized generic‐controlled evaluation of cardiovascular medications [J] . Alatawi Y., Rahman Md. M., Cheng N., Journal of Clinical Pharmacy and Therapeutics . 2018,第3期

机译：品牌VS通用不良事件报告模式：授权通用控制的心血管药物评估
2. Methodological Considerations for Comparison of Brand Versus Generic Versus Authorized Generic Adverse Event Reports in the US Food and Drug Administration Adverse Event Reporting System (FAERS) [J] . Md. Motiur Rahman, Yasser Alatawi, Ning Cheng, Clinical drug investigation . 2017,第12期

机译：与泛型与授权通用不良事件报告的品牌与授权通用不良事件报告的方法论考虑不良事件报告系统（FAEERS）
3. Patterns in Spontaneous Adverse Event Reporting Among Branded and Generic Antiepileptic Drugs [J] . Bohn J., Kortepeter C., Munoz M., Clinical Pharmacology and Therapeutics . 2015,第5期

机译：品牌和通用抗癫痫药中自发不良事件报告的模式
4. Evaluation of Transfer Learning for Adverse Drug Event (ADE) and Medication Entity Extraction [C] . Sankaran Narayanan, Kaivalya Mannam, Sreeranga P. Rajan, Clinical natural language processing workshop . 2020

机译：对不良药物事件（ADE）和药物实体提取的转移学习评价
5. Cardiovascular Adverse Events in Patients Receiving QT Interval Prolonging Medications [D] . Ye, Yizhou. 2017

机译：接受QT间隔延长药物治疗的患者的心血管不良事件
6. Brand vs. generic adverse event reporting patterns: an authorized generic-controlled evaluation of cardiovascular medications [O] . Yasser Alatawi, Md. Motiur Rahman, Ning Cheng, -1

机译：品牌与非常规不良事件报告模式：经授权的非常规对照药物对心血管药物的评估
7. Methodological Considerations for Comparison of Brand Versus Generic Versus Authorized Generic Adverse Event Reports in the US Food and Drug Administration Adverse Event Reporting System (FAERS) [O] . Md. Motiur Rahman, Yasser Alatawi, Ning Cheng, 2017

机译：与泛型与授权通用不良事件报告的品牌与授权通用不良事件报告的方法论考虑不良事件报告系统（FAEERS）

Brand vs generic adverse event reporting patterns: An authorized generic-controlled evaluation of cardiovascular medications

著录项

引文网络

相似文献

相关主题

期刊订阅